Cyberdyne HAL
With Optomotion now distributing CYBERDYNE, we introduce the pioneering promise of advanced, innovative, and effective neurorehabilitation through the world’s first wearable cyborg.
CYBERDYNE Inc., established in June 2004, aims to share the research findings of Professor Yoshiyuki Sankai from the University of Tsukuba for public benefit. HAL® Therapy offers medical treatment utilizing Robot Suit HAL® to enhance functionality for patients with various cerebral, nervous, and muscular disorders, including spinal cord injury and cerebral embolism.
Chemocare
Now that Optomotion is distributing ChemoCare, we’re proud to offer you the assurance of safe, precise, and efficient electronic chemotherapy prescribing and patient management.
ChemoCare is reshaping cancer care with state-of-the-art technology. Trusted by 85% of NHS centers across England, Scotland, and Wales, our electronic chemotherapy prescribing system has become integral to cancer treatment in the UK. ChemoCare guarantees enhanced patient outcomes and streamlined clinical workflows.
Chemocare
Now that Optomotion is distributing ChemoCare, we’re proud to offer you the assurance of safe, precise, and efficient electronic chemotherapy prescribing and patient management.
ChemoCare is reshaping cancer care with state-of-the-art technology. Trusted by 85% of NHS centers across England, Scotland, and Wales, our electronic chemotherapy prescribing system has become integral to cancer treatment in the UK. ChemoCare guarantees enhanced patient outcomes and streamlined clinical workflows.
Partner with Us Today!
